Itpc Latca Opposition, Nirmatrelvir/Ritonavir, (Hn/P/2021/002695 Wo2021250648)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
Thai Network of People Living with HIV/AIDS (TNP+) opposition, Molnupiravir (MK-4482), (PCT/US2021/016984)
Countries: Thailand Date: 2025
-
AIDS ACCESS FOUNDATION AND THAI NETWORK FOR PEOPLE WITH HIV/AIDS opposition, Remdesivir (GS-5734), (WO/2016/069826)
Countries: Thailand Date: 2021
-
AIDS ACCESS FOUNDATION AND THAI NETWORK FOR PEOPLE WITH HIV/AIDS opposition, Remdesivir (GS-5734), (WO/2012/012776)
Countries: Thailand Date: 2021
-
Fundación Grupo Efecto Positivo opposition, Remdesivir (GS-5734), (AR102468)
Countries: Argentina Date: 2021
-
Cancer Patient Aid Association (CPAA) opposition, Molnupiravir, (201717025098)
Countries: India Date: 2021
-
Entrepreneurship Development Center opposition, Molnupiravir, (201717025098)
Countries: India Date: 2021
-
Prathiba Sivasubramanian opposition, Molnupiravir, (201717025098)
Countries: India Date: 2021
-
Keelu Lakshminarayana opposition, Molnupiravir, (202017019418)
Countries: India Date: 2021
-
Vietnam National Network of People Living with HIV/AIDS (VNP+) opposition, Nirmatrelvir and Ritonavir [PAXLOVID], (VN1-2021-07603 / WO/2021/250648)
Countries: Viet Nam Date: 2023
-
Fundación Grupo Efecto Positivo opposition, Nirmatrelvir and Ritonavir [PAXLOVID], (AR123111A1)
Countries: Argentina Date: 2022